Cancer reproducibility effort faces backlash
I can't state how strongly I disagree with the conclusion that papers should be providing excruciating detail about protocol just because "pharmaceutical companies can't reproduce key cancer papers [without the help of the original scientists]". Science has rarely been done like this.It would be like Google complaining that they can't copy psuedocode verbatim out of a paper and have a highly performant algorithm. Or Microsoft complaining that a static analysis defined in a paper wasn't accompanied by a production-ready implementation.Producing protocols that literally anyone could replicate without expending effort is not the business of Science.Replication should focus on the veracity of the underlying truth claim, not the economics of reproducing the results.